Gene · 6431
Papers1,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aspartyl-tRNA synthetase 2 orchestrates iron-sulfur metabolism in hematopoietic stem cells via fine-tuning alternative RNA splicing. | Cell Rep | 2023 | 37838946 | PubTator, text mining | PubMed |
| H1Innovative approaches to combat anti-cancer drug resistance: Targeting lncRNA and autophagy. | Clin Transl Med | 2023 | 37837401 | PubTator, text mining | PubMed |
| Contribution of ADD3 and the HLA Genes to Biliary Atresia Risk in Chinese. | Int J Mol Sci | 2023 | 37834180 | PubTator, text mining | PubMed |
| USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC. | Cell Death Dis | 2023 | 37821439 | PubTator, text mining | PubMed |
| Editor's note on 'Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene'. | Nucleic Acids Res | 2023 | 37791846 | PubTator, text mining | PubMed |
| Identification of two short peptide motifs from serine/arginine-rich protein ribonucleic acid recognition motif-1 domain acting as splicing regulators. | PeerJ | 2023 | 37744237 | PubTator, text mining | PubMed |
| Transcriptional linkage analysis with in vivo AAV-Perturb-seq. | Nature | 2023 | 37730998 | PubTator, text mining | PubMed |
| Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India. | BMC Cancer | 2023 | 37718447 | PubTator, text mining | PubMed |
| On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine. | J Virol | 2023 | 37706687 | PubTator, text mining | PubMed |
| Isochromosome 7p, i(7)(p10): A rare AML, myelodysplasia-related entity. | Leuk Res Rep | 2023 | 37701905 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| Towards understandings of serine/arginine-rich splicing factors. | Acta Pharm Sin B | 2023 | 37655328 | PubTator, text mining | PubMed |
| Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis. | Medicine (Baltimore) | 2023 | 37653757 | PubTator, text mining | PubMed |
| Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities. | Cancers (Basel) | 2023 | 37568815 | PubTator, text mining | PubMed |
| Mutations Causing X-Linked Amelogenesis Imperfecta Alter miRNA Formation from Amelogenin Exon4. | J Dent Res | 2023 | 37563801 | PubTator, text mining | PubMed |
| Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation. | EMBO Mol Med | 2023 | 37519267 | PubTator, text mining | PubMed |
| Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing. | Genes (Basel) | 2023 | 37510291 | PubTator, text mining | PubMed |
| A single nuclei atlas of aging human abdominal subcutaneous white adipose tissue. | Res Sq | 2023 | 37503028 | PubTator, text mining | PubMed |
| The Role of miR-1183: A Potential Suppressor in Hepatocellular Carcinoma via Regulating Splicing Factor SRSF1. | J Hepatocell Carcinoma | 2023 | 37497429 | PubTator, text mining | PubMed |
| A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma. | Hereditas | 2023 | 37482612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6431/papers?page=5